Roche provides update on Alzheimer’s Prevention Initiative study evaluating crenezumab in autosomal dominant Alzheimer’s disease
June 16, 2022
Categories: Advancements in Alzheimer's diseaseJune 16, 2022
Categories: Advancements in Alzheimer's disease